BioVie Inc

BIVI

Company Profile

  • Business description

    BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer’s disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

  • Contact

    680 W Nye Lane
    Suite 204
    CarsonNV89703
    USA

    T: +1 775 888-3162

    E: [email protected]

    https://www.bioviepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    14

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.1048.200.55%
CAC 407,878.46111.751.44%
DAX 4024,549.56342.651.42%
Dow JONES (US)44,458.30217.540.49%
FTSE 1008,867.0212.840.15%
HKSE23,911.4619.140.08%
NASDAQ20,611.34192.870.94%
Nikkei 22539,618.13203.15-0.51%
NZX 50 Index12,737.5931.02-0.24%
S&P 5006,263.2637.740.61%
S&P/ASX 2008,589.7051.100.60%
SSE Composite Index3,502.779.720.28%

Market Movers